As a result, the level of circulating APOC3 increases and acts as alipoprotein lipase inhibitor, leading to decreased clearance of TG-rich particles, which ultimately result in hypertriglyceridemia [42, 43]. Here, APOC3 is linked to hypertriglyceridemia.